Finance

Lists
Why is MANE down 2,40%?
Dive Deeper
MANE:NYSE
Veradermics Inc
US$113,47
-2,40%
(-2,79) 1D
US$113,00
-0,41% (-0,47)
After hours
Closed: 14 ຕ.ລ., 16 ໂມງ 0 ນາທີ 02 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MANE...
Open
US$115,35
High
US$118,91
Low
US$112,62
Mkt. cap
4,74 ຕື້
Avg. vol.
836,64 ພັນ
Volume
487,64 ພັນ
52-wk high
US$136,72
52-wk low
US$32,00
EPS
US$-3,35
No. of employees
37
Open
US$115,35
High
US$118,91
Low
US$112,62
Mkt. cap
4,74 ຕື້
Avg. vol.
836,64 ພັນ
Volume
487,64 ພັນ
52-wk high
US$136,72
52-wk low
US$32,00
EPS
US$-3,35
No. of employees
37
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
The Daily News | Texas' Oldest Newspaper
·
52 ນາທີກ່ອນ
FILE PHOTO: SK Hynix at the Nasdaq market in New York
Yardeni QuickTakes
Yardeni QuickTakes
·
28 ນາທີກ່ອນ
Continue To Proceed With Caution
Simply Wall Street
Simply Wall Street
·
21 ນາທີກ່ອນ
Marvell Technology And 2 Other High Growth Stocks To Own
Bloomberg.com
Bloomberg.com
·
6 ຊົ່ວໂມງກ່ອນ
S&P 500 Ends Longest Streak of Calm Since 2020 as AI Trade Sinks
About Veradermics Inc
CEO-
Employees37
Founded2019
Headquartersນິວຮາເວນ, ຄອນເນັກຕິຄັດ, ສະຫະລັດ
SectorPharmaceutical industry
Websiteveradermics.com
Analyst ratings
Based on 5 analysts giving stock ratings to MANE in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for MANE in the last 3 months.
Highest
Current US$113,47
US$182,00 (+60,39%)
Average
US$169,20 (+49,11%)
Lowest
US$160,00 (+41,01%)
Analyst
Recommendation
Action
Price target
Projected
Date
Geoff Meacham
Citi
Buy
Maintained
US$160,00
+41%
09/15/2026
Roger Song
Jefferies
Buy
Maintained
US$182,00
+60,4%
09/08/2026
Unknown Analyst
Jefferies
Buy
Maintained
US$182,00
+60,4%
09/08/2026
Serge Belanger
Needham
Buy
Maintained
US$164,00
+44,5%
08/12/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
US$170,00
+49,8%
08/11/2026
Mayank Mamtani
B. Riley Securities
Buy
Initiated
US$170,00
+49,8%
07/15/2026
Marc Goodman
Leerink Partners
Buy
Initiated
US$75,00
-33,9%
03/02/2026
Prakhar Agrawal
Cantor Fitzgerald
Buy
Initiated
-
-
03/01/2026
Last report
11 ສ.ຫ. 2026
Fiscal period
Q2 2026
US$-0,58 / US$-0,64
+9,56%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ມິ.ຖ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
14,33 ລ້ານ
18,19 ລ້ານ
20,92 ລ້ານ
18,61 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,74 ລ້ານ
4,82 ລ້ານ
8,94 ລ້ານ
10,95 ລ້ານ
Operating expense
16,07 ລ້ານ
23,01 ລ້ານ
29,86 ລ້ານ
29,55 ລ້ານ
Total operating expenses
16,07 ລ້ານ
23,01 ລ້ານ
29,86 ລ້ານ
29,55 ລ້ານ
Operating income
-16,07 ລ້ານ
-23,01 ລ້ານ
-29,86 ລ້ານ
-29,55 ລ້ານ
Other non operating income
325,00 ພັນ
258,00 ພັນ
149,00 ພັນ
1,21 ລ້ານ
EBT including unusual items
-15,64 ລ້ານ
-21,85 ລ້ານ
-27,23 ລ້ານ
-23,50 ລ້ານ
EBT excluding unusual items
-15,64 ລ້ານ
-21,85 ລ້ານ
-27,23 ລ້ານ
-23,50 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-15,64 ລ້ານ
-21,85 ລ້ານ
-27,23 ລ້ານ
-23,50 ລ້ານ
Net profit margin
-
-
-
-
Earnings per share
-
-104,54
-1,32
-0,58
Interest and investment income
103,00 ພັນ
906,00 ພັນ
2,48 ລ້ານ
4,84 ລ້ານ
Interest expense
-
-
-
-
Net interest expenses
103,00 ພັນ
906,00 ພັນ
2,48 ລ້ານ
4,84 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
ແອັບຂອງ Google